Clinical Trials Directory

Trials / Conditions / Histoplasmosis

Histoplasmosis

16 registered clinical trials studyying Histoplasmosis — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingHistoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT)
NCT07261150
University of MinnesotaPhase 3
CompletedRandomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients
NCT04059770
Alessandro PasqualottoPhase 2
WithdrawnAdditive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama
NCT02911740
University of FloridaN/A
CompletedStudy to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractor
NCT03059992
Scynexis, Inc.Phase 3
CompletedA Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers
NCT02493738
Boryung Pharmaceutical Co., LtdPhase 1
CompletedA Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and
NCT00784368
Janssen Pharmaceutical K.K.Phase 3
CompletedSubmacular Surgery Trials (SST)
NCT00000150
National Eye Institute (NEI)Phase 3
CompletedPhase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
NCT00004808
National Center for Research Resources (NCRR)Phase 2
CompletedPhase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
NCT00004811
National Center for Research Resources (NCRR)Phase 1 / Phase 2
UnknownMacular Photocoagulation Study (MPS)
NCT00000158
National Eye Institute (NEI)Phase 3
CompletedPilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of
NCT00000627
National Institute of Allergy and Infectious Diseases (NIAID)N/A
CompletedA Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients
NCT00002438
Janssen, LPN/A
CompletedWithdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV D
NCT00006316
National Institute of Allergy and Infectious Diseases (NIAID)—
CompletedA Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
NCT00000992
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedA Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Am
NCT00002159
Janssen, LPPhase 3
CompletedA Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients Wit
NCT00000975
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2